As of July 19, 2022, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus and its associated infectious disease coronavirus disease 2019 (COVID-19) have …

Background Fatigue is the most prevalent and debilitating long-COVID (coronavirus
disease) symptom; however, risk factors and pathophysiology of this condition remain …

Background Severe fatigue can persist for months after coronavirus disease 2019 (COVID-
19) onset. This longitudinal study describes fatigue severity and its determinants up to 12 …

The Guidance Statement1 represents the collective expertise of providers who have treated
thousands of patients across the United States and are predicated on ever evolving …

Introduction Increasing evidence on long-term health outcomes following SARS CoV-2
infection shows post-viral symptoms can persist for months. These symptoms are often …

The World Health Organization (WHO) declared COVID-19 a pandemic in 2020 after its
spread to 190 nations [2]. Research has shown that a new human infectious disease …

Large numbers of individuals who have been infected with SARS-CoV-2, the virus
responsible for COVID-19, continue to experience a constellation of symptoms long past the …

(1) Background: After an acute SARS-CoV-2 infection, patients are at risk of developing
Long COVID, with fatigue as a frequent and serious health problem. Objectives: To identify …

Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019
(COVID-19)(sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue …

As of March 2023, over 761 million confirmed cases of coronavirus disease 2019 (COVID-
19) have been confirmed worldwide, leading to more than 6.8 million deaths. 1 Although …